Stockholders' Equity

6 Months Ended

Jun. 30, 2024

Equity [Abstract]

Stockholders' Equity

13. Stockholders’ Equity

Zoetis is authorized to issue 6 billion shares of common stock and 1 billion shares of preferred stock.

In December 2021, our Board of Directors authorized a $3.5 billion multi-year share repurchase program. As of June 30, 2024, there was $623 million remaining under this authorization. In August 2024, our Board of Directors authorized a new multi-year share repurchase program of up to $6 billion of our outstanding common stock. See Note 17. Subsequent Events for additional information. Purchases of Zoetis shares may be made at the discretion of management, depending on market conditions, business needs and available liquidity.

Accumulated other comprehensive loss

Changes, net of tax, in accumulated other comprehensive loss, were as follows:

			Currency Translation Adjustments
					Other Currency		Benefit Plans		Accumulated Other
	Cash Flow		Net Investment		Translation		Actuarial		Comprehensive
(MILLIONS OF DOLLARS)	Hedges		Hedges		Adjustments		Gains/(Losses)		Loss
Balance, December 31, 2023	$	85	$	18	$	(944)	$	2	$	(839)
Other comprehensive (loss)/income, net of tax	(1)		18		(23)		—		(6)
Balance, June 30, 2024	$	84	$	36	$	(967)	$	2	$	(845)
Balance, December 31, 2022	$	90	$	41	$	(944)	$	(4)	$	(817)
Other comprehensive (loss)/income, net of tax	(3)		(13)		(66)		4		(78)
Balance, June 30, 2023	$	87	$	28	$	(1,010)	$	—	$	(895)